{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-003314","form_type":"8-K","ticker":"LTRN","cik":"0001763950","company_name":"Lantern Pharma Inc.","filed_at":"2026-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.106033+00:00","generated_at":"2026-05-16T08:27:56.324469+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Lantern Pharma demonstrates AI tools for rare cancers at Jan 22 event","bullets":["Event hosted on Jan 22, 2026 to showcase initial AI tools and multi-agentic system for rare cancers.","Presentation furnished as Exhibit 99.1; no financial results or clinical data disclosed.","Company discusses AI-driven drug development platform, but no specific milestones or partnerships announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-003314","json":"https://secwatch.observer/filing/0001493152-26-003314.json","markdown":"https://secwatch.observer/filing/0001493152-26-003314.md","text":"https://secwatch.observer/filing/0001493152-26-003314.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1763950/000149315226003314/0001493152-26-003314-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1763950/000149315226003314/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T08:27:56.324469+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}